Mitochondrial anchoring of PKCα by PICK1 confers resistance to etoposide-induced apoptosis

Apoptosis

Volumn 12, Issue 10, 2007, Pages 1857-1871

  Wang, Wei Li ^a   Yeh, Sheau Farn ^a   Huang, Eagle Yi Kung ^b   Lu, Yu Ling ^a   Wang, Chun Fa ^a   Huang, Chi Ying F ^a,c   Lin, Wey Jinq ^a,d  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^d TAIPEI CITY HOSPITAL   (Taiwan)

Author keywords

Anchoring protein; Apoptosis; PICK1; PKC ; Signal transduction

Indexed keywords

12 (2 CYANOETHYL) 6,7,12,13 TETRAHYDRO 13 METHYL 5 OXOINDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE; ETOPOSIDE; PEPTIDE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN INTERACTING WITH PROTEIN KINASE C; PROTEIN KINASE C ALPHA; ANTINEOPLASTIC AGENT; CARBAZOLE DERIVATIVE; CARRIER PROTEIN; ENZYME INHIBITOR; INDOLE DERIVATIVE; NUCLEAR PROTEIN; PRKCABP PROTEIN, MOUSE; SERINE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL ACTIVITY; CELL STRAIN HL 60; CELL SURVIVAL; CONTROLLED STUDY; DIMERIZATION; DRUG MECHANISM; ENZYME ACTIVITY; FIBROBLAST; GENE OVEREXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; LEUKEMIA CELL; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; MUTANT; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; WILD TYPE; ANIMAL; CELL LINE; CELL STRAIN 3T3; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; METABOLISM; MOUSE; PHYSIOLOGY;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CARBAZOLES; CARRIER PROTEINS; CELL LINE; DIMERIZATION; ENZYME INHIBITORS; ETOPOSIDE; HUMANS; INDOLES; MICE; MITOCHONDRIA; NIH 3T3 CELLS; NUCLEAR PROTEINS; PEPTIDES; PROTEIN KINASE C-ALPHA; PROTO-ONCOGENE PROTEINS C-BCL-2; SERINE;

EID: 34848834834     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-007-0098-0     Document Type: Article

References (52)

1. Nakashima S, Protein kinase C (2002) alpha (PKC alpha): regulation and biological function. J Biochem (Tokyo) 132:669-675
2. Ng T, Squire A, Hansra G et al (1999) Imaging protein kinase Calpha activation in cells. Science 283:2085-2089
3. Vallentin A, Prevostel C, Fauquier T, Bonnefont X, Joubert D (2000) Membrane targeting and cytoplasmic sequestration in the spatiotemporal localization of human protein kinase C alpha. J Biol Chem 275:6014-6021
4. Eude I, Dallot E, Ferre F, Breuiller-Fouche M (2002) Protein kinase Calpha is required for endothelin-1-induced proliferation of human myometrial cells. Biol Reprod 66:44-49
5. Mochly-Rosen D, Gordon AS (1998) Anchoring proteins for protein kinase C: a means for isozyme selectivity. FASEB J 12:35-42
6. Jaken S, Parker PJ (2000) Protein kinase C binding partners. Bioessays 22:245-254
7. Jiffar T, Kurinna S, Suck G et al (2004) PKC alpha mediates chemoresistance in acute lymphoblastic leukemia through effects on Bcl2 phosphorylation. Leukemia 18:505-512
8. Spitaler M, Wiesenhofer B, Biedermann V et al (1999) The involvement of protein kinase C isoenzymes alpha, epsilon and zeta in the sensitivity to antitumor treatment and apoptosis induction. Anticancer Res 19:3969-3976
9. Nguyen M, Millar DG, Yong VW, Korsmeyer SJ, Shore GC (1993) Targeting of Bcl-2 to the mitochondrial outer membrane by a COOH-terminal signal anchor sequence. J Biol Chem 268:25265-25268
10. Ruvolo PP, Deng X, Carr BK, May WS (1998) A functional role for mitochondrial protein kinase Calpha in Bcl2 phosphorylation and suppression of apoptosis. J Biol Chem 273:25436-25442
11. Borner C (2003) The Bcl-2 protein family: sensors and checkpoints for life-or-death decisions. Mol Immunol 39:615-647
12. Poole AW, Pula G, Hers I, Crosby D, Jones ML (2004) PKC-interacting proteins: from function to pharmacology. Trends Pharmacol Sci 25:528-535
13. Lee HS, Millward-Sadler SJ, Wright MO, Nuki G, Al-Jamal R, Salter DM (2002) Activation of Integrin-RACK1/PKCalpha signalling in human articular chondrocyte mechanotransduction. Osteoarthritis Cartilage 10:890-897
14. Perez JL, Khatri L, Chang C, Srivastava S, Osten P, Ziff EB (2001) PICK1 targets activated protein kinase Calpha to AMPA receptor clusters in spines of hippocampal neurons and reduces surface levels of the AMPA-type glutamate receptor subunit 2. J Neurosci 21:5417-5428
15. Wang WL, Yeh SF, Chang YI et al (2003) PICK1, an anchoring protein that specifically targets protein kinase Calpha to mitochondria selectively upon serum stimulation in NIH 3T3 cells. J Biol Chem 278:37705-37712
16. Staudinger J, Zhou J, Burgess R, Elledge SJ, Olson EN (1995) PICK1: a perinuclear binding protein and substrate for protein kinase C isolated by the yeast two-hybrid system. J Cell Biol 128:263-271
17. Staudinger J, Lu J, Olson EN (1997) Specific interaction of the PDZ domain protein PICK1 with the COOH terminus of protein kinase C-alpha. J Biol Chem 272:32019-32024
18. Dev KK (2004) Making protein interactions druggable: targeting PDZ domains. Nat Rev Drug Discov 3:1047-1056
19. Lin WJ, Chang YF, Wang WL, Huang CY (2001) Mitogen-stimulated TIS21 protein interacts with a protein-kinase-Calpha-binding protein rPICK1. Biochem J 354:635-643
20. Takeya R, Takeshige K, Sumimoto H (2000) Interaction of the PDZ domain of human PICK1 with class I ADP-ribosylation factors. Biochem Biophys Res Commun 267:149-155
21. Chang CD, Meienhofer J (1978) Solid-phase peptide synthesis using mild base cleavage of N alpha-fluorenylmethyloxycarbonylamino acids, exemplified by a synthesis of dihydrosomatostatin. Int J Pept Protein Res 11:246-249
22. Smyth PG, Berman SA (2002) Markers of apoptosis: methods for elucidating the mechanism of apoptotic cell death from the nervous system. Biotechniques 32:648-650, 652, 654
23. Madsen KL, Beuming T, Niv MY et al (2005) Molecular determinants for the complex binding specificity of the PDZ domain in PICK1. J Biol Chem 280:20539-20548
24. Fawell S, Seery J, Daikh Y et al (1994) Tat-mediated delivery of heterologous proteins into cells. Proc Natl Acad Sci USA 91:664-668
25. Martiny-Baron G, Kazanietz MG, Mischak H et al (1993) Selective inhibition of protein kinase C isozymes by the indolocarbazole Go 6976. J Biol Chem 268:9194-9197
26. Degterev A, Boyce M, Yuan J (2003) A decade of caspases. Oncogene 22:8543-8567
27. Sohn D, Schulze-Osthoff K, Janicke RU (2005) Caspase-8 can be activated by interchain proteolysis without receptor-triggered dimerization during drug-induced apoptosis. J Biol Chem 280:5267-5273
28. Deng X, Kornblau SM, Ruvolo PP, May WS Jr (2001) Regulation of Bcl2 phosphorylation and potential significance for leukemic cell chemoresistance. J Natl Cancer Inst Monogr 28:30-37
29. Ito T, Deng X, Carr B, May WS (1997) Bcl-2 phosphorylation required for anti-apoptosis function. J Biol Chem 272:11671-11673
30. Romano MF, Avellino R, Petrella A, Bisogni R, Romano S, Venuta S (2004) Rapamycin inhibits doxorubicin-induced NF-kappaB/Rel nuclear activity and enhances the apoptosis of melanoma cells. Eur J Cancer 40:2829-2836
31. Brichese L, Barboule N, Heliez C, Valette A (2002) Bcl-2 phosphorylation and proteasome-dependent degradation induced by paclitaxel treatment: consequences on sensitivity of isolated mitochondria to Bid. Exp Cell Res 278:101-111
32. Antonsson B, Montessuit S, Lauper S, Eskes R, Martinou JC (2000) Bax oligomerization is required for channel-forming activity in liposomes and to trigger cytochrome c release from mitochondria. Biochem J 345(2):271-278
33. Antonsson B, Montessuit S, Sanchez B, Martinou JC (2001) Bax is present as a high molecular weight oligomer/complex in the mitochondrial membrane of apoptotic cells. J Biol Chem 276:11615-11623
34. Langeberg LK, Scott JD (2005) A-kinase-anchoring proteins. J Cell Sci 118:3217-3220
35. Dell'Acqua ML, Dodge KL, Tavalin SJ, Scott JD (2002) Mapping the protein phosphatase-2B anchoring site on AKAP79. Binding and inhibition of phosphatase activity are mediated by residues 315-360. J Biol Chem 277:48796-48802
36. Dev KK, Nakajima Y, Kitano J, Braithwaite SP, Henley JM, Nakanishi S (2000) PICK1 interacts with and regulates PKC phosphorylation of mGLUR7. J Neurosci 20:7252-7257
37. Mahajan NP, Linder K, Berry G, Gordon GW, Heim R, Herman B (1998) Bcl-2 and Bax interactions in mitochondria probed with green fluorescent protein and fluorescence resonance energy transfer. Nat Biotechnol 16:547-552
38. Oltvai ZN, Milliman CL, Korsmeyer SJ (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74:609-619
39. Mikhailov V, Mikhailova M, Pulkrabek DJ, Dong Z, Venkatachalam MA, Saikumar P (2001) Bcl-2 prevents Bax oligomerization in the mitochondrial outer membrane. J Biol Chem 276:18361-18374
40. Wilson-Annan J, O'Reilly LA, Crawford SA et al (2003) Proapoptotic BH3-only proteins trigger membrane integration of prosurvival Bcl-w and neutralize its activity. J Cell Biol 162:877-887
41. Cory S, Huang DC, Adams JM (2003) The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene 22:8590-8607
42. Yamamoto K, Ichijo H, Korsmeyer SJ (1999) BCL-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G(2)/M. Mol Cell Biol 19:8469-8478
43. Blagosklonny MV, Giannakakou P, el-Deiry WS et al (1997) Raf-1/bcl-2 phosphorylation: a step from microtubule damage to cell death. Cancer Res 57:130-135
44. Halestrap AP, McStay GP, Clarke SJ (2002) The permeability transition pore complex: another view. Biochimie 84:153-166
45. Boudin H, Craig AM (2001) Molecular determinants for PICK1 synaptic aggregation and mGluR7a receptor coclustering: role of the PDZ, coiled-coil, and acidic domains. J Biol Chem 276:30270-30276
46. Nourry C, Grant SG, Borg JP (2003) PDZ domain proteins: plug and play! Sci STKE 2003:RE7
47. Doyle DA, Lee A, Lewis J, Kim E, Sheng M, MacKinnon R (1996) Crystal structures of a complexed and peptide-free membrane protein-binding domain: molecular basis of peptide recognition by PDZ. Cell 85:1067-1076
48. Lahn M, Su C, Li S et al (2004) Expression levels of protein kinase C-alpha in non-small-cell lung cancer. Clin Lung Cancer 6:184-189
49. Gravitt KR, Ward NE, Fan D, Skibber JM, Levin B, O'Brian CA (1994) Evidence that protein kinase C-alpha activation is a critical event in phorbol ester-induced multiple drug resistance in human colon cancer cells. Biochem Pharmacol 48:375-381
50. Mandil R, Ashkenazi E, Blass M et al (2001) Protein kinase Calpha and protein kinase Cdelta play opposite roles in the proliferation and apoptosis of glioma cells. Cancer Res 61:4612-4619
51. Leirdal M, Sioud M (1999) Ribozyme inhibition of the protein kinase C alpha triggers apoptosis in glioma cells. Br J Cancer 80:1558-1564
52. Hanauske AR, Sundell K, Lahn M (2004) The role of protein kinase C-alpha (PKC-alpha) in cancer and its modulation by the novel PKC-alpha-specific inhibitor aprinocarsen. Curr Pharm Des 10:1923-1936